<p>Factors associated with HIV RNA <1000 copies/ml among HIV patients receiving first-line ART at 12 months in four sentinel antiretroviral treatment sites.</p
<p>3TC, lamivudine; aOR, adjusted odds ratio; ABC, abacavir; AZT, zidovudine; CI, confidence interva...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, years; ART, antir...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
<p>Odds ratios from uni- and multivariable logistic regressions are shown with 95% confidence interv...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients who achieved HIV-1 RNA < 50 copies p...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients who achieved HIV-1 RNA < 400 copies ...
<p>*CD4<sup>+</sup> T cells count in cells/mm<sup>3</sup>;</p><p>**HIV RNA level: copies/ml</p><p>Fa...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients with HIV-1 RNA reduction ≥1 log<sub>...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
<p>Proportion of subjects with plasma HIV-1 RNA<48 copies/mL and <200 copies/mL using the Intention-...
To characterize selection factors related to therapy initiation, the authors investigated the extent...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, months; ART, anti...
To assess the effects of sex, risk group, age at and year of seroconversion (SC), and presentation d...
BACKGROUND: Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïve HIV-in...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
<p>3TC, lamivudine; aOR, adjusted odds ratio; ABC, abacavir; AZT, zidovudine; CI, confidence interva...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, years; ART, antir...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
<p>Odds ratios from uni- and multivariable logistic regressions are shown with 95% confidence interv...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients who achieved HIV-1 RNA < 50 copies p...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients who achieved HIV-1 RNA < 400 copies ...
<p>*CD4<sup>+</sup> T cells count in cells/mm<sup>3</sup>;</p><p>**HIV RNA level: copies/ml</p><p>Fa...
<p>Mantel-Haenszel odds ratio of ART experienced HIV-1 patients with HIV-1 RNA reduction ≥1 log<sub>...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
<p>Proportion of subjects with plasma HIV-1 RNA<48 copies/mL and <200 copies/mL using the Intention-...
To characterize selection factors related to therapy initiation, the authors investigated the extent...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, months; ART, anti...
To assess the effects of sex, risk group, age at and year of seroconversion (SC), and presentation d...
BACKGROUND: Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïve HIV-in...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
<p>3TC, lamivudine; aOR, adjusted odds ratio; ABC, abacavir; AZT, zidovudine; CI, confidence interva...
#<p>, cells/µl;</p>&<p>, HIV RNA copies per ml plasma (log<sub>10</sub>);</p>*<p>, years; ART, antir...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...